EditCo logo
EditCo logo

EditCo

editco.bio
editco.bio • Founded 2018 • Likely startup • New
Founded 2018 • Likely startup • New
Actively hiring
Synthetic Biology
Cell & Gene Therapy
Biotechnology
As featured in
Yahoo Finance
The Scientist
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Telegraph Hill Partners
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2018 Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Telegraph Hill Partners fund
Similar startupsby what they do, their industry and backers
Cell MicrosystemsVenture round $6.5M · 3 yr ago • Founded 2021 • 51-200 employees
Cell Microsystems develops innovative tools that allow researchers to image, sort, and isolate single cells and colonies for use in the…
KytopenVenture round $7.1M · 19 mo ago • Founded 2017 • 51-200 employees
Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing…
Applied StemCellVenture round $19M · 10 yr ago • Founded 2008 • 51-200 employees
Our powerful, patented genome engineering technologies and iPSC expertise enable the next wave of advanced therapeutics.
Logomix201-500 employees • 10 roles
Logomix is a Japan-based synthetic biology company that develops genome engineering technologies for human cells. Its Geno-Writing platform…
Form BioVenture round $16M · 4 yr ago • Founded 2022 • 51-200 employees • 1 role
Form Bio accelerates genetic medicine with AI—optimizing AAV vectors, enhancing CRISPR accuracy, boosting yields up to 4.4x, and improving…
Celaid Therapeutics
セレイドセラピューティクス - 細胞治療(造血幹細胞). Change the futurewith cell therapy.

Overview

EditCo provides CRISPR gene editing services, CRISPR products & genome engineering solutions for disease models, drug discovery and cell therapy research.

News